Status:
COMPLETED
Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)
Lead Sponsor:
AstraZeneca
Conditions:
Congestive Heart Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
A study to evaluate the effect of Atacand on patients with heart failure with preserved left ventricular function
Eligibility Criteria
Inclusion
- Male or female aged 18 or above
- Congestive Heart Failure with symptoms for more than 4 weeks before starting study
- Provision of informed consent
Exclusion
- Current low blood pressure with symptoms
- Liver disease considered significant by the study doctor
- Pregnant or lactating females
Key Trial Info
Start Date :
June 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2003
Estimated Enrollment :
734 Patients enrolled
Trial Details
Trial ID
NCT00634712
Start Date
June 1 1999
End Date
May 1 2003
Last Update
January 25 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.